Search alternatives:
ng decrease » nn decrease (Expand Search), _ decrease (Expand Search), we decrease (Expand Search)
n decrease » nn decrease (Expand Search), _ decrease (Expand Search), _ decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
5 ng » 5 mg (Expand Search), 5 g (Expand Search), 5 nm (Expand Search)
Showing 81 - 100 results of 77,936 for search '(( a n decrease ) OR ((( 5 ng decrease ) OR ( 5 ((ng decrease) OR (a decrease)) ))))', query time: 1.17s Refine Results
  1. 81
    Source data for Fig 2.

    Source data for Fig 2. by Rahsan Erdem (11726357)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  2. 82
    Consolidated Standards for Reporting of Trials flow diagram.

    Consolidated Standards for Reporting of Trials flow diagram. by Rahsan Erdem (11726357)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  3. 83
    iOWH032 inhibits cholera toxin-induced fecal output in a cecectomized rat model.

    iOWH032 inhibits cholera toxin-induced fecal output in a cecectomized rat model. by Rahsan Erdem (11726357)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  4. 84
    Source data for Fig 3.

    Source data for Fig 3. by Rahsan Erdem (11726357)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  5. 85
    Scatterplot of iOWH032 plasma concentrations versus diarrheal stool output rate.

    Scatterplot of iOWH032 plasma concentrations versus diarrheal stool output rate. by Rahsan Erdem (11726357)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  6. 86
    Reverse cumulative distribution plot for diarrheal stool output rate overall in the modified intent-to-treat population.

    Reverse cumulative distribution plot for diarrheal stool output rate overall in the modified intent-to-treat population. by Rahsan Erdem (11726357)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  7. 87
    Diarrheal disease severity by treatment group for the modified intent-to-treat population.

    Diarrheal disease severity by treatment group for the modified intent-to-treat population. by Rahsan Erdem (11726357)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  8. 88
    Reference mutations versus background noise across replicates.

    Reference mutations versus background noise across replicates. by Lizhi Yu (12476136)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  9. 89
    Quantification and accuracy of average VAF.

    Quantification and accuracy of average VAF. by Lizhi Yu (12476136)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  10. 90
    Analytical sensitivity and reproducibility.

    Analytical sensitivity and reproducibility. by Lizhi Yu (12476136)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  11. 91
    Depth of coverage and heterogeneity of the mutation loci. x-axis, mutation loci in sample set one or two; y-axis, depth of coverage after UMI consolidation.

    Depth of coverage and heterogeneity of the mutation loci. x-axis, mutation loci in sample set one or two; y-axis, depth of coverage after UMI consolidation. by Lizhi Yu (12476136)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  12. 92
    Impact of mutation type on VAF quantification performance.

    Impact of mutation type on VAF quantification performance. by Lizhi Yu (12476136)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  13. 93
    Schematic overview of the cross-platform study.

    Schematic overview of the cross-platform study. by Lizhi Yu (12476136)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  14. 94
    Impact of DNA extraction process on depth of coverage.

    Impact of DNA extraction process on depth of coverage. by Lizhi Yu (12476136)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  15. 95
    CXCL10 production is enhanced in the setting of HIV and HBV co-infection in vitro and decreased with the addition of antiretroviral agents efavirenz or raltegravir.

    CXCL10 production is enhanced in the setting of HIV and HBV co-infection in vitro and decreased with the addition of antiretroviral agents efavirenz or raltegravir. by Kasha P. Singh (9354307)

    Published 2020
    Save to List
    Saved in:
  16. 96
    p38 MAPK inhibitor decreases ALDH2 expression in AML cells in the presence of TGF-β1 or stromal cells.

    p38 MAPK inhibitor decreases ALDH2 expression in AML cells in the presence of TGF-β1 or stromal cells. by Bin Yuan (19897)

    Published 2020
    Save to List
    Saved in:
  17. 97
    IODVA1 inhibits lamellipodia and circular dorsal ruffle (CDR) formation in MDA-MB-231 cells and decreases Rac activation.

    IODVA1 inhibits lamellipodia and circular dorsal ruffle (CDR) formation in MDA-MB-231 cells and decreases Rac activation. by Anjelika Gasilina (8566296)

    Published 2020
    Save to List
    Saved in:
  18. 98
    Time adjusted survival curves for high vs. low renalase among patients with COVID-19 disease (using first quartile as cutoff).

    Time adjusted survival curves for high vs. low renalase among patients with COVID-19 disease (using first quartile as cutoff). by Basmah Safdar (12213257)

    Published 2022
    Save to List
    Saved in:
  19. 99
    Urine cytokines levels and renal histology (n = 69).

    Urine cytokines levels and renal histology (n = 69). by Pintip Ngamjanyaporn (5618255)

    Published 2022
    Save to List
    Saved in:
  20. 100
    Decrease in arginine and increase in citrulline after NEI-01 administration.

    Decrease in arginine and increase in citrulline after NEI-01 administration. by Jeremy P. H. Chow (8788208)

    Published 2020
    Save to List
    Saved in:

Search Tools: